Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil and Nesiritide in Preclinical Heart Failure
NCT01544998Phase 2Completed
- Sponsor
- Mayo Clinic
- Start
- Feb 2012
- Primary completion
- Aug 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nesiritide and tadalafil in heart failure (HF) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Change in Natriuresis (Urinary Sodium Excretion) at 60 minutes. Started Feb 2012; status: completed.
02
Drugs
nesiritidetadalafil
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01544998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01544998.